TrialBritish journal of cancer2009

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.

I Ray-Coquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.